FilingReader Intelligence

Fosun Pharma invests in United Family Healthcare

March 31, 2025 at 05:16 PM UTCBy FilingReader AI

Shanghai Fosun Pharmaceutical Group (SSE:600196) is investing in United Family Healthcare Insurance, a related party, alongside the International Finance Corporation (IFC) and the Asian Development Bank (ADB). The three entities will invest CNY 270 million each, which will increase Fosun Pharma’s stake in United Family Healthcare from 14.00% to 20.05%. United Family Healthcare Insurance will still qualify as a joint venture. The investment is subject to regulatory approval from the China Banking and Insurance Regulatory Commission. Fosun Pharma also announced the resignation of Senior Vice President, Bao Qingui, due to personal reasons. Bao Qingui will no longer be with the company, as of March 31st, 2025. Fosun Pharma expressed their gratitude to Bao Qingui for his service to the company.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600196Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →